Safety of a novel oral single-agent fumarate, BG00012, in patients with relapsing-remitting multiple sclerosis: results of a phase 2 study

Author
Eraksoy, M.
O'Neill, G. N.
Yang, M.
Meluzinova, E.
Rektor, I.
Gold, R.
Havrdova, E.
Kappos, L.
Limmroth, V.
Miller, D.
Polman, C.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/91352
Collections